Int. J. Dev. Biol. 61: 5-15 (2017)
doi: 10.1387/ijdb.160408gv
www.intjdevbiol.com
Trunk neural crest cells: formation, migration and beyond
GUILLERMO A. VEGA-LOPEZ#,1, SANTIAGO CERRIZUELA#,1 and MANUEL J. AYBAR*,1,2,
1
Instituto Superior de Investigaciones Biológicas (INSIBIO, CONICET-UNT) and 2Instituto de Biologia “Dr. Francisco
D. Barbieri”, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, Argentina
ABSTRACT Neural crest cells (NCCs) are a multipotent, migratory cell population that generates
an astonishingly diverse array of cell types during vertebrate development. The trunk neural crest
has long been considered of particular significance. First, it has been held that the trunk neural
crest has a morphogenetic role, acting to coordinate the development of the peripheral nervous
system, secretory cells of the endocrine system and pigment cells of the skin. Second, the trunk
neural crest additionally has skeletal potential. However, it has been demonstrated that a key role
of the trunk neural crest streams is to organize the innervation of the intestine. Although trunk
NCCs have a limited capacity for self-renewal, sometimes they become neural-crest-derived tumor
cells and reveal the fact that that NCCs and tumor cells share the same molecular machinery. In
this review we describe the routes taken by trunk NCCs and consider the signals and cues that pattern these trajectories. We also discuss recent advances in the characterization of the properties of
trunk NCCs for various model organisms in order to highlight common themes. Finally, looking to
the future, we discuss the need to translate the wealth of data from animal studies to the clinical
area in order to develop treatments for neural crest-related human diseases.
KEY WORDS: trunk neural crest, migration, neurogenesis, enteric nervous system, neurocristopathies
Introduction
One characteristic that separates vertebrates from other metazoans is the cell population called the neural crest (NC). This embryonic tissue is composed of cells arising at the border between
the non-neural ectoderm and neural ectoderm. This population
is also characterized by having multipotent and stem-cell-like
properties. After being induced, neural crest cells (NCCs) undergo
a process known as epithelial-to-mesenchymal transition (EMT)
and migrate to distinct locations within the embryo to generate a
wide diversity of cell derivatives (Duband et al., 1995, Kerosuo
and Bronner-Fraser, 2012).
With the exception of the most anterior part of the embryo, NCCs
are generated along the entire length of the anterior-posterior (AP)
axis. Derivative tissues arising from the NC originate from four different segments of the AP axis: cranial, cardiac, vagal and trunk
NC. The cranial NC participates in the formation of the cartilage
and bone of the head, nerve ganglia, smooth muscle, connective
tissue and pigment cells. The cardiac NC participates in heart
development, while the vagal NC contributes to the enteric ganglia
of the gut. Finally, the trunk NC will give rise to neurons and glia of
the peripheral nervous system (PNS), secretory cells of the endocrine system and pigment cells of the skin (Etchevers et al., 2001).
The understanding of the development of the NC has important
medical implications since a variety of birth defects arise from
abnormal processes in the induction, specification and migration
of NCCs and affect NC derivatives postnatally. These abnormalities, called neurocristopathies, are one of the most common birth
defects in live-born infants, including defects in the cardiac outflow tract, craniofacial malformations, familial dysautonomia, and
a range of syndromes including Tracher-Collins, Waardenburg,
DiGeorge and Charge syndromes (Etchevers et al., 2006). It is
thus of crucial importance to develop experimental approaches
that will allow the suitable dissection of the cellular and genetic
features of human NCCs.
Abbreviations used in this paper: AP, antero-posterior; BMP, bone morphogenetic
protein; DRG, dorsal root ganglia; ECM, extracellular matrix; EMT, epithelialto-mesenchymal transition; ENS, enteric nervous system; Eph, ephrin receptor;
FGF, fibroblast growth factor; NC, neural crest; NCCs, neural crest cells; NCSCs,
neural crest stem cells; NT, neural tube; RA, retinoic acid; tNC, trunk neural crest;
tNCCs, trunk neural crest cells; Sem, semaphorin; Shh, Sonic hedgehog.
*Address correspondence to: Manuel J. Aybar. Instituto Superior de Investigaciones Biológicas (INSIBIO, CONICET-UNT), Chacabuco 461. San Miguel de Tucumán,
Argentina. Tel.: +54-381-4107214. E-mail:
[email protected] - #Both authors contributed equally
http://orcid.org/0000-0002-7187-6435
Supplementary Material for this paper is available at: http://dx.doi.org/10.1387/ijdb.160408gv
Submitted: 4 November 2016; Accepted: 12 December 2016.
ISSN: Online 1696-3547, Print 0214-6282
© 2017 UPV/EHU Press
Printed in Spain
6
G. A. Vega-Lopez et al.
The stem and pluripotent properties of NCCs, combined with
an exceptional diversity of cell type and cell differentiation, have
made NCCs an interesting target in regenerative medicine. This
is sustained by the fact that NC stem cells (NCSCs) are retained
postnatally in the skin, peripheral nerves, gut, heart and bone
marrow (Dyachuk et al., 2014).
One of the most remarkable properties of the NC is its striking
similitude to malignant cancer cells. Malignant tumor cells mimic
many behavioral and morphological aspects of NC development.
Loss of apicobasal polarity, changes in adhesion, degradation
of the ECM, cell proliferation, migration and pluripotency are
mechanisms shared by both cell types as they go to their final
destinations and differentiate (Kerosuo and Bronner-Fraser, 2012,
Maguire et al., 2015).
During the past two decades numerous investigations have
documented the induction, specification, delamination and migration of trunk NCCs (tNCCs). Despite this fact, more work is needed
to provide straightforward evidence concerning the application
of tNCCs in the regeneration of specific cell types, in the repair
of damaged tissue and in the potential therapies against various
types of cancer.
In this review we will focus on the formation of the trunk NC and
its molecular events, and the delamination and migration pathways.
We will also address the difference in molecular signature and
behavior of the tNCCs between different species, and the differentiation into diverse derivatives. Finally, we will outline several
applications of tNCCs in regenerative medicine and cancer therapy.
into three streams: adjacent to the neural tube from the diencephalon
to rhombomere 2(r2), adjacent to r4, and adjacent to the postotic
region from r6 to r8. NCCs from r3 and r5 migrate rostrally and
caudally to join adjacent streams (Kulesa et al., 2010, Kuriyama
and Mayor, 2008, Lumsden and Guthrie, 1991). The mechanism
and processes involved in cranial NC induction, delamination and
migration have been extensively reviewed elsewhere (Gong, 2014,
Minoux and Rijli, 2010), and other references).
Trunk NCCs arise from the caudal region of the embryo and
migrate along three different pathways: a dorsolateral pathway
between the ectoderm and the somites, a ventro-lateral pathway
in which cells migrate between and through the somites, and a
ventro-medial pathway between the neural tube (NT) and the posterior sclerotome (Gammill and Roffers-Agarwal, 2010, Krispin et
al., 2010, McLennan et al., 2015, Richardson et al., 2016). Therefore, the pathways taken by the tNCCs and their final destinations
are critically influenced by the surrounding structures, particularly
somites and signaling molecules present in this tissue and those
from surrounding ones.
The physical structure of the somite provides different kinds
of attractive and inhibitory cues that modulate NCCs migration
and differentiation. For example, somites are crucial as physical
impediments, as a substrate for migration, and as a source of
signals. Another case of influence on NC migration comes from
the notochord. It repels migratory NCCs, causing them to gather
at the dorsal aorta where they differentiate into sympathetic glia
(Gammill and Roffers-Agarwal, 2010).
Trunk neural crest - overview
Induction and multipotency of tNCCs: signals that guide
their development
As mentioned above, the NC gives rise to multiple organs and
tissues of the adult organism. The two major population of the NC
are the cranial NC and the trunk NC (tNC). Cranial NCCs migrate
D
Neural Crest
NF
P
A
Dkk, Cer
Wnt, FGF, RA
BMP
V
Fig. 1. Model of neural crest (NC) initial induction. Dorsolateral view
of a schematic model embryo. A ventro-medial gradient of BMPs (red) is
established in the ectoderm, specifying the neural plate border as neural
fold (NF, brown) at a threshold concentration. Posteriorizing signals (green)
which correspond to the activities of Wnts, FGFs and RA transform the
lateral and posterior part of the neural plate border into prospective NC
cells (blue). These signals are also generated in a gradient-like manner, with
higher levels in the posterior part of the ectoderm and lower levels in the
anterior region. These lower anterior levels are also kept low by antiposteriorizing molecules such as Dickkopf and Cerberus (Wnts antagonists,
Dkk and Cer), in pink, produced in the anterior region of the embryo. A,
anterior; P, posterior; D, dorsal; V, ventral. Modified figure from Niehrs
(2004), redrawn and upgraded.
NC progenitors are induced at the neural plate border as a
consequence of the integration of complex signaling events involving the BMP, Wnt, RA and FGF pathways (Fig. 1) (Aybar and
Mayor, 2002). The signaling molecules and transcription factors
that are required for NC specification, maintenance of the specification, migration and differentiation can be explained as a gene
regulatory network that defines their individual and combinatorial
roles in transcriptional regulation (Betancur et al., 2010a). The
transcription factors involved in such processes can be grouped
according to their biological role into neural plate border specifiers, NC specifiers, NC/EMT migration factors, and factors that
direct the differentiation of NCCs into specific derivative cell types
(Taylor and LaBonne, 2007). More specifically, it is known that in
the tNC the transcription factors sox9, foxd3 and slug are sufficient
to specify NCCs and induce EMT (Cheung et al., 2005, Liu et al.,
2013, Nitzan et al., 2013). It is important to note that perhaps due
to current experimental limitations or to the intrinsic complexities of
each model organism analyzed, it has not been possible at present
to find inductive mechanisms unique to each particular region of
the NC. However, it has been reported that some differences do
exist in the development of cranial versus tNCC (i.e. at the onset
of gene expression), although similar mechanisms are implicated
in NC formation (Osorio et al., 2009).
With respect to the NC potency and migration suggested, it
has been proposed that there could be three possible scenarios
relating to the properties of the pool of premigratory NCCs. In one
case the NC may be assumed to be a homogeneous population
of totipotent cells, each with a remarkable developmental poten-
Trunk neural crest cells
tial. Following migration, the cells could differentiate according to
instructive cues from their surroundings, either during migration
or at their final destination. In the second case the potentiality
of each cell could be characteristic of its NC population. In this
scenario, the NC would be composed of a heterogeneous mixture
of predetermined cells, each destined to become a particular cell
type. A third possibility is that the NC represents a combination
of multipotent and predetermined cells (Fig. 2, green and yellow
cells) (McKinney et al., 2013). Over the past 25 years since the
establishment of these three putative models, numerous investigations have been performed to assess this basic question about
the potentiality of NCCs. One group of investigations concluded
that NCCs were multipotent in vivo (McKinney et al., 2013) and
in vitro (Dupin and Sommer, 2012). However, other publications
reported that the NC was formed by a heterogeneous population
of restricted progenitor cells (Krispin et al., 2010). Recently, it has
been shown that the vast majority of NCCs, at least in the case of
the murine embryo, are multipotent prior to and during migration
(Baggiolini et al., 2015, Bronner, 2015).
EMT and delamination of trunk NCCs
After NCCs have been induced and have become pluripotent
to differentiate into various types of derivatives they undergo EMT
(epithelial-to-mesenchymal transition). In this transition they delaminate from the NT or from the neuroepithelium and convert from
epithelium-like cells to mesenchyme-like cells, which are capable
of migrating along the entire embryo (Kerosuo and Bronner-Fraser,
7
2012, Nieto, 2009).
The EMT is thought to be promoted by the activation of BMP
and a simultaneous upregulation of the Wnt signaling pathway
(Ahlstrom and Erickson, 2009). Before and after delaminating from
the NT and during their migration there is an extensive and complex
network of up- and down-regulation of cell adhesion molecules
such as cadherins, connexins, occludins and integrins (Taneyhill,
2008). In chick embryos, neural fold cells express cadherin-6B
(Nakagawa and Takeichi, 1995). An important factor in the start
of migration of NC cells is the downregulation of N-cadherin. This
requires the coordinated action of BMP signaling and the proteolytic
action of the transmembrane protein ADAM10, which cleaves the
extracellular domain of N-cadherin (Osorio et al., 2009, Shoval et
al., 2007). In the case of the Xenopus embryo, cadherin-11 has
an important function, and is expressed in the anterior neural
folds and in migrating NCCs (Vallin et al., 1998). In the zebrafish
embryo, the Sonic Hedgehog (Shh) receptor and cell adhesion
regulator, Cdon, has been shown to play a key role in the directed
migration of tNCCs, by regulating N-cadherin localization (Powell
et al., 2015). Thus the process of EMT in tNCC is more complex
than previously thought, involving several signal molecules and
secreted factors, with the addition of cell adhesion molecules, all
of which are involved in a complex regulatory network.
Regional differences between cranial and tNCCs
The molecular mechanisms governing the induction and specification of NCCs vary in accordance to the axial level. An early
ect
5
Fig. 2. Trunk neural crest cell migration. In the trunk of the embryo,
neural crest cells (NCCs) migrate in
the following ways: (1) a minority of
NCCs move ventrally through the
dorsal anterior sclerotome (a permissive but not preferred substrate) by
traveling laterally on myotomal basal
lamina to form: a) dorsal root ganglia,
b) sympathetic ganglia and c) adrenal
medulla; (2) between the neural
tube and somites to give rise to the
sympathetic and sensory ganglia;
(3) ventrally between the somites
along intersomitic vessels. (4) After
ventral migration is complete, NCCs
leave the staging area and enter the
-multipotent NCC
dorso-lateral path between the ectoderm and the anterior sclerotome.
-predetermined NCC
(5) They also migrate dorso-laterally
under the ectoderm and over the
-fibronectin and
dermomyotome to give rise to the
pigment cells of the skin (melanolaminin
blasts or feathers). Differences in
“species-specific” cell surface molecules dictate the various cell migration behaviors. A feature-rich model of the trunk NC migratory streams of this
figure is shown in an interactive 3D-pdf in Supplementary Fig. 1. Adapted from Dr. Brian E. Staveley, Memorial University of Newfoundland, redrawn and
upgraded. a, dorsal aorta; a-scl, anterior sclerotome; dm, dermomyotome; ect, ectoderm; nc, notochord; nt, neural tube; p-scl, posterior sclerotome; v, vein.
1
2
3 4
nt
dm
scl
v
a
nc
p-scl
a-scl
a v
dmect
8
G. A. Vega-Lopez et al.
difference between cranial and trunk NCCs is the expression of a
distinctive gene marker. In the case of cranial NCCs, the marker
that differentiates them from the trunk NC is the ets-1 gene (Theveneau et al., 2007), whereas a bona fide tNC marker has not yet
been found. The kinesin eg5, another early gene with expression
in the pre-delamination trunk stage, and ednrb2-c during migration, could be good candidates as well (Fernandez et al., 2014,
Kawasaki-Nishihara et al., 2011, Square et al., 2016).
Another regional difference is the distinct regulation of NC specifier genes. For example, the NC specifier gene, namely foxd3, has
an enhancer region that receives different inputs with respect to
the axial level. The cranial NC enhancer requires an Ets-1 input,
whereas the trunk enhancer requires Zic1. Thus there are differential
inputs mediating foxd3 expression in cranial NC versus trunk NC
(Simoes-Costa et al., 2012). Another case of differential regulation
of protein expression is that of sox10. In cranial NCCs the sox10
gene expression is driven by the sox10E2 enhancer, while in trunk
NC the enhancer is sox10E1 (Betancur et al., 2010b).
Going into the delamination phase of NC development, there are
also differences in the regulation of this process between cranial and
trunk NCCs. In mouse and chicken cranial NCCs, the transcription
factor Sip1 is essential for the delamination of the cells (Rogers et
al., 2013). On the other hand, in tNCCs, besides the participation
of the Sip1 protein, the transcription factor δEF1 is also required
for NCC delamination (Yasumi et al., 2016).
Patterning of NC cells into distinct streams and their precise
targeting to specific tissues are controlled by a plethora of negative
and positive guidance cues than can work by two different models, follow-the-leader or cell-cell-contact. In the follow-the-leader
model, leader and follower identities are acquired before the start
of migration and remain fixed after that (Kelsh et al., 2009, Kuo
and Erickson, 2010, McLennan et al., 2012, Wynn et al., 2013).
In the cell-cell contact, the cell needs a co-attraction and contact
inhibition of locomotion, and identities could be acquired after the
onset of migration (Broders-Bondon et al., 2016, Szabo and Mayor,
2016). In chick and zebrafish it has been shown that whereas
cranial NCCs do not require leader cells for their migration and
all the cells present similar migratory capacities, tNCCs require
leader cells to direct movement and cell-cell contact. It has also
been shown that the leader and follower identities are acquired
before the initiation of the migration and remain fixed after that
(Richardson et al., 2016). This could also be an intrinsic difference
between cranial and tNC that lies in the migration mechanism.
The tNCC migration routes
Right after delamination, the NCCs of the trunk region of the
embryo start to migrate along three different routes (Fig. 2). The
first NCCs that delaminate and migrate start doing so in a ventral
way around the epithelial somites, mostly along blood vessels in
the intersomitic space. They also migrate between the somites
and the NT. After the somites have matured and dissociated into
dermomyotome and sclerotome, a second set of NCCs begins to
invade the sclerotome and migrate ventrolaterally through different parts of the somite, depending upon the particular species of
organism (Serbedzija et al., 1990). A third wave of NCCs migrate
along a dorsolateral pathway between the epidermal ectoderm and
the dermomyotome (Erickson et al., 1992). The possible mechanisms guiding or controlling the migration of each cellular group are
discussed below. An increasing amount of evidence suggests that
the transition from ventral to dorsal pathway preference is NCCs
autonomous and not due to changes in the environment (Kuo and
Erickson, 2011, Simkin et al., 2013).
Species-specific differences in tNC migration pathways
Developmental biology has taught us that the development of
very different species is strikingly similar. Nonetheless, regarding
the timing and trajectories of migration of trunk NCCs, there are
a few differences between the four major model organisms, i.e.
Xenopus laevis, Mus musculus, Gallus gallus and Danio rerio.
In mouse and chick embryos, tNCCs start migrating ventrally in
a non-segmented way between the NT and the somites, favoring
the intersomitic space. After the maturation of the somite, NC cells
pass through the anterior half of the sclerotome and along the basement membrane of the dermomyotome (Hall, 2008). As mentioned
above, the third pathway undertaken by tNCCs is the dorsolateral
one. In mouse embryos both routes are invaded simultaneously,
while in chick this third wave invades the dorsolateral pathway with
a 48-hour delay (Kuo and Erickson, 2010).
In zebrafish, trunk NCCs start migrating along a medial pathway
in-between the somites and the NT. These NCCs align to and are
affected by slow muscle cells in the middle part of the somite (Honjo
and Eisen, 2005). After 4hs of the start of migration through the
medial pathway, NCCs commence migrating on the dorsolateral
pathway between the epidermis and the somite (Raible et al.,
1992). In contrast to other species, zebrafish melanocytes precursors are composed of NCCs arriving from the dorsal pathway as
well as from the medial pathway (Kelsh et al., 2009). In Xenopus,
as opposed to chick and mouse, trunk NCCs pass through the
caudal region of the somite during their ventromedial migration.
In addition, few NCCs migrate along the lateral pathway under the
ectoderm (Collazo et al., 1993).
The migration of the NC has been studied not only in these
major vertebrate organisms, but also in more basal vertebrates
such as the lamprey and hagfish. In lamprey we can distinguish
three major NC populations: the trigeminal crest (TC), the hyoid
crest (HC) and the branchial crest (BC). Although the head-trunk
differentiation in the lamprey is not yet completed and there is no
clear differentiation in trunk and cranial NC in this species, BC
cells can be considered similar to tNC since the branchial region
is expanded caudally. In regard to their migration, BC cells are
found superficially to the arch mesoderm, indicating that these
cells migrate along the dorsolateral pathway (Mukendi et al., 2016).
All the results mentioned above stress the fact that migration of
NCCs varies between different species and among various phyla.
Light traffic control during tNCC migration
tNCCs have the potential to differentiate into a multitude of cell
derivatives including neurons and glia of the sensory and autonomic
nervous system. Such cell derivatives also include the neurons and
glia of the dorsal root (DRG) and sympathetic ganglia, Schwann
cells that line the ventral roots, adrenal chromaffin cells, pigment
cells (melanocytes), cells from the adrenal medulla thyroid glands
and the neurons of the enteric nervous system (ENS) (Le Douarin
and Kalcheim, 1999). Besides the genetically encoded potentiality
of NCCs to become a specific derivative, the final differentiation of
these cells depends to a large extent on the environment through
which they migrate and the cues that they receive. To reach their
Trunk neural crest cells
final destination NCCs emit and receive signals that are crucial
to determine the path they go through. In the paragraphs below
we explain in detail the signals and factors that modulate tNCCs
migration.
In the three migratory pathways described before, the proteins
laminin and fibronectin are permissive substrates for NC migration.
In chick, fish and frog, one of the first cues that direct recently delaminated NCCs to go ventrally to the sclerotome is the chemokine
Cxcl12, which attracts Cxcr4 expressing NCCs to the dorsal aorta
(Fig. 3) (Gordon et al., 2011).
In mouse and chick, migrating tNCCs are restricted to the
anterior sclerotome because they express the receptors EphrinA/B (Eph-A/B) while the posterior sclerotome expresses Ephrin-B
ligands (Baker and Antin, 2003). Another restriction to the migration
of NCCs in the somite is the expression pattern of semaphorins
ect
1
nt
dm
scl
B
dnR
3/E
Edn 3a
C
(Sem). Dermomyotome cells express Sem3A, which prevents
Neuropilin-1 positive NCCs from entering it (Fig. 3), while the
caudal sclerotome expresses Sem3F, which restricts Neuropilin-2
expressing cells to the anterior part of the somite (Fig. 3) (Schwarz
et al., 2009). The semaphorin guidance cue is potentiated by proteoglycans (F-spondin and Versicans) that are expressed in the
caudal sclerotome (Casini et al., 2008). The role of Eph/Ephrin
and semaphorin pathways in Xenopus and zebrafish tNC migration has not been assessed yet, thus providing an interesting field
for future research.
The signaling Slit/Robo is essential in preventing tNCCs from
entering the dorsolateral pathway and restricting them to the ventral
one. The dermomyotome secretes the Slit protein, which prevents
Robo-expressing NC from entering the dorsolateral pathway (Fig.
3) (Jia et al., 2005). Another recently found role of the Slit/Robo
34
5
EphB1
Edn
2B
Eph 3F
Sem
a-scl
nc
v a
g
a
24
9
p-scl
din
F-Spon
in
s Artem
Versican
A
Sem3
dmect
Slit
NF
GD
v
12
CL
CX reg
u
Ne
EphA
Receptors
Neuropilin 1
CXCR4
EphB2
Neuropilin 2
Erb2/3
EdnrB2
tNC pathways
Robo
repulsion
attraction
Fig. 3. Environmental cues guiding trunk neural crest migration. (1) After delaminating from the neural trunk, trunk neural crest cells (tNCCs) migrate
along various streams. (2) Ventromedial pathway: cells expressing Cxcr4 are attracted by the ligand Cxcl12. Neuregulin attracts Enrb2/3 expressing cells.
C3a and GDNF from the gut mesenchyme attracts cells expressing receptors C3ar and GFRa1, respectively. Also, endothelin3 is an attractant of cells
expressing EdnrB. Finally, the Slit factor excludes Robo expressing cells from entering the gut. (3) Ventrally between the somites along intersomitic
vessels, by Artemin atraction. (4a) Ventrolateral pathway across the somites: Eph2B and Sem3F signals repel EphA and Neuropilin1 expressing cells,
respectively. (4b) Slit and Sem3A generate a repulsive signal from the dermomyotome to cells expressing Robo and Neuropilin1, respectively. This
prevents cell migration from the sclerotome to the dermomyotome. (5) Dorsolateral pathway: NCCs along this pathway are attracted to migrate between
the dermomyotome and the ectoderm by EphB1 and Endothelin proteins which attracts cells expressing EphB2 and EdnrB2 receptors, respectively. a,
dorsal aorta; a-scl, anterior sclerotome; dm, dermomyotome; ect, ectoderm; g, gut; nc, notochord; nt, neural tube; p-scl, posterior sclerotome; v, vein.
10
G. A. Vega-Lopez et al.
signaling is the restriction to the entrance of tNCCs into the developing gut. Slit expressing cells that are near the entrance to the
gut generate a negative cue to migrating tNCCs that express the
receptor Robo (Fig. 3) (Zuhdi et al., 2015).
The diffusible protein Draxin, which is better known for its role
as an axon guidance molecule, has an inhibiting role as a signaling cue during chick and mouse NC migration. In the first wave of
migration, Draxin expressed in the dorsal lip of the dermomyotome
restricts early migrating NC cells from entering the dorsolateral
pathway. This inhibitory function lies in the ability of Draxin to alter
cell polarization by cytoskeleton remodeling (Zhang et al., 2016)
As expressed above, cadherins are important in the process
of EMT and during the migration of trunk NCCs. In regard to the
migration of NCCs through the anterior part of the sclerotome,
T-cadherins are essential to reduce the adhesion of NCCs to the
caudal sclerotome (Ranscht and Bronner-Fraser, 1991).
The cells that migrate along the ventrolateral pathway reaching the dorsal aorta are guided by four distinct signaling cues.
Neuregulin from the mesenchyme around the dorsal aorta attracts
Erb2/3 expressing NCCs to the ventral side to pass the sclerotome (Fig. 3) (Fantauzzo and Soriano, 2015). The second signal
is the above mentioned Cxcl12 chemokine which attracts NCCs
expressing Cxcr4 to the dorsal aorta. In addition to these signals,
the neurotrophic factor Artemin, secreted by the peripheral blood
vessel cells, attracts NC sympathetic precursors and allows their
proliferation (Fig. 3, stream 3) (Honma et al., 2002). The fourth
signal has a repulsive mechanism; Sem3A expressed in limbs,
dermomyotome and notochord restricts Neuropilin-1 expressing
NCCs near the dorsal aorta (Kawasaki et al., 2002).
Zebrafish tNCCs require Notch/Delta signaling. The trunk region
contains an equivalence domain of cells that can become RohonBeard cells but, when exposed to Notch/Delta signaling, become
tNC instead (McGraw et al., 2012). During their migration along
the ventrolateral pathway, NC cells not only receive signals from
the environment but also induce certain changes in neighboring
tissues. For instance, tNCCs migrating underneath the dermomyotome trigger myogenesis by transiently activating Notch/Delta
signaling in muscle precursors (Rios et al., 2011).
Apart from the vast evidence and information about the ventromedial pathway in mouse and chick, little is known about the particular
molecular cues that guide Xenopus tNCCs to this ventromedial
pathway. Further work is needed to understand the underlying
mechanisms that govern the migration of Xenopus tNCCs.
Migration of tNCCs along the dorsolateral pathway is controlled by several signaling molecules. Cells that are determined
to the melanocytic lineage upregulate Eph-B2 and are attracted
to the dorsal ectoderm by Ephrin-B1 (Fig. 3) (Santiago and Erickson, 2002). The dorsolateral route contains Endothelins, which
prevents EdnrB-expressing neuronal and glial precursors from
entering the dorsolateral pathway and at the same time stimulate
EdnrB2-expressing melanocytic precursors to the migration onto
this pathway (Harris et al., 2008). In the case of the mouse, the kit
ligand expressed in the dermomyotome attracts melanoblasts that
express the kit receptor (Wehrle-Haller et al., 2001). Also in mouse,
the chemokine Sdf1 guides the melanocytes from the skin to the
hair follicle (Belmadani et al., 2009). Not only particular guidance
molecules direct the migration of tNCCs but entire tissues do so
as well. It has been shown that the emerging dermis supplies a yet
uncharacterized diffusible attractant that stimulates melanoblasts
to enter the dorsal pathway (Tosney, 2004)
In contrast to the vast quantity of cells that enter the dorsolateral
pathway in mouse and chick, in Xenopus only a small portion of
cells migrate through this pathway; they use the medial pathway
instead and then move laterally, below the somites, to reach the
epidermis (Collazo et al., 1993). In the case of zebrafish, NCCs
use both the ventromedial and the dorsolateral pathway to form
melanocyte derivatives (Kelsh et al., 2009).
The directionality of the migration of tNCCs cannot emerge only
from a balance of positive and negative cues that promotes the
invasion of specific areas of the embryo. The interplay between
inhibiting signals and attracting cues cannot fully explain the overall
directionality in the migration of tNCCs. Therefore, it is more likely
that this directed migration is controlled on a local scale in between
a certain migratory stream.
For this reason extensive research has been done to understand the molecular mechanisms that delineate the movements
of the NCCs during their migration. In Xenopus laevis it has been
shown that the collective migration of NCCs involve a combination
of mechanisms, including contact inhibition of locomotion (CIL),
repolarization, chemoattraction and coattraction, at least in the
case of cranial NCCs. More specifically, it is known that NCCs are
attracted to each other via ligand receptor interaction mediated by
Complement3a (C3a) and the C3a receptor (Broders-Bondon et
al., 2016). These cells are also attracted by a secreted factor called
SDF, which plays a key role in patterning NC cells into forward
moving streams. This factor is expressed in the ectoderm facing
the early migrating NCCs (Theveneau et al., 2010).
Recently, molecular level-studies and computational simulations were performed to analyze the intrinsic molecular signature
within an NCC migratory stream. The results showed that there
are regional differences in gene expression within a particular
NC stream and that there is a consistent and stable molecular
signature unique to the cells in the distal portion of the migratory
stream (McLennan et al., 2015).
Signaling pathways involved in the specification and
differentiation of tNCCs
After migrating along the three pathways mentioned before,
the NCCs settle in discrete sites and differentiate into diverse cell
types. This process of cell differentiation requires the deployment
of differentiation gene batteries, which are sets of genes that confer
its terminal identity to each cell (Erwin and Davidson, 2009). Gene
batteries are controlled by different drivers, which are regulators
that control the transition between the progenitor and differentiated states (Peter and Davidson, 2015). The SoxE transcription
factors are important in activating differentiation gene batteries
during NC differentiation. More particularly, Sox10 is involved in
the differentiation of NCCs into neurons, glia and melanocytes
(Kelsh, 2006), while Sox9 participates in the stimulation towards a
chondrocyte fate (Mori-Akiyama et al., 2003). The misexpression
of SOX10 during NC development in human causes WaardenburgHirschsprung disease (Pingault et al., 1998).
Since migratory NCCs are multipotent, environmental cues play
a key role in determining the fate of their progeny. These cues are
integrated by the signaling pathways that are active in the cells
along the migratory route. In this section we describe the different
molecules and signaling pathways involved in the differentiation
Trunk neural crest cells
of tNCCs into their particular derivatives.
Kit signaling is essential in the differentiation of NC into melanocytes (Parichy et al., 1999). Furthermore, MitfA and Sox10 are crucial to promote melanoblast specification. However, subsequently,
MitfA-dependent activation of the histone deacetylase complex
Hdac1 represses sox10 expression in melanoblasts, promoting
both differentiation and fate commitment (Greenhill et al., 2011).
In addition, BMP has been shown to participate in the differentiation of cells into the autonomic nervous system lineage (Saito
et al., 2012), whereas the Wnt pathway has been associated with
the formation of sensory neurons and melanocytes (Lee et al.,
2004). Another example of a signaling pathway responsible for
the differentiation of NCCs is the Endothelin-receptor B signaling,
which is required for enteric nerve cell formation and melanocyte
development (Dupin and Le Douarin, 2003). It has been suggested
that another receptor of the same family, the Endothelin receptor
A, plays a key role in the induction of Xenopus laevis melanocytes
(Bonano et al., 2008). Also in Xenopus, a study has shown that
the Edn3-Ednrb2 signal is required for the migration of melanoblasts and that the receptor is expressed in melanoblast while the
ligand Edn3 is expressed at the destination sites of their migration
(Kawasaki-Nishihara et al., 2011).
Another signaling molecule important for the differentiation
of tNC into a specific cell type is Retinoic Acid, which influences
cells to develop as sympathetic neurons (Ito and Morita, 1995).
Moreover, ErbB/Neuregulin signaling is involved in tNC migration
and differentiation into DRG sensory neurons and sympathetic
ganglia (Britsch et al., 1998).
Until now we have only discussed the signaling molecules
and survival factors involved in the formation of trunk NC derivatives. However, these factors inevitably cooperate to activate a
transcriptional cascade that in turn establishes the functional and
morphological changes that are coincident with differentiation. For
example, the transcription factor Achaete-scute homolog 1 (Ascl)
is the first indicator of neuronal differentiation in the autonomic
lineage (Groves et al., 1995). It is also a master proneural gene for
the specification of the sympathetic lineage (Sommer et al., 1995).
Another important regulator for the development of the autonomic
nervous system is the transcription factor Phox2b, which is hierarchically equivalent to Ascl1 (Pattyn et al., 1999). In regard to another
aspect of PNS development, Hand1 and Hand2 transcription factors
are important in the acquisition of noradrenergic characteristics
among the peripheral system neurons (Morikawa et al., 2005). In
the development of the sensory nervous system, signaling by the
Trk receptors is of vital importance during the neurogenesis of the
DRG (Fantauzzo and Soriano, 2015).
The enteric neural system (ENS) is formed from enteric NCCs
(ENCCs) migrating from the vagal and sacral region, which colonize the entire length of the gut wall forming all the neurons of the
enteric system. The ENS is sometimes called the “second brain”
because of the diversity of neuronal cell types and complex,
integrated circuits that permit the ENS to autonomously regulate
many processes in the bowel (Panza et al., 2012). The signaling
through the receptor tyrosine kinase gene, RET, is essential for
ENS development (Panza et al., 2012). The receptors involved
in this signaling are the glial cell line-derived neurotrophic factor (GDNF) and its glycosylphosphatidylinositol (GPI)-anchored
coreceptor, GFRa1. Expression of Ret and Gfra1 is activated in
ENCCs upon entry into the foregut, whereas Gdnf is detected in
11
gut mesenchyme prior to ENCCs arrival in the foregut (Natarajan
et al., 2002). The Endothelin B signaling pathway through the Endothelin 3 ligand and the EdnrB receptor has also a very important
role in the development of the ENS, for the mutation in the genes
of these proteins delay colonization in the gut (Lee et al., 2003)
Even though knowledge about the differentiation mechanisms
in the NC is continuously growing, further work is required to address all the steps necessary to transform a multipotent migratory
NC cell into a differentiated progenitor.
NCCs and tumor cells: two distinct but similar cell
populations
Cancer cells use certain molecular and genetic tools similar to
developing NCCs. Malignant cells mimic many of the behavioral,
genetic, molecular and morphological aspects of NC development
(Karunasena et al., 2015, Kerosuo and Bronner-Fraser, 2012,
Maguire et al., 2015, Nguyen et al., 2009).
In cancer cells, TGFb and Wnt are upregulated. There is also
an increase in the signaling by tyrosine kinase receptors (Thiery
and Sleeman, 2006). These upregulated signaling pathways are
reminiscent of the BMP, Wnt and FGF signals implicated in NC
induction and the BMP/Wnt cascade that triggers the EMT. In
addition, the Hippo/Yap signaling, which has known roles in the
migration of cancer cells, has recently been described as promoting
an early NC phenotype (multipotency) and migration which occur
during human NC development (Hindley et al., 2016, Uribe and
Bronner, 2015). This emphasizes the relationship between NC
development and cancer progression.
After delaminating from their original place, NCCs and tumor
cells undergo solitary and collective cell migration. Both of these
cell types use existing tissues and cellular structures to migrate
and colonize new territory; i.e. tumor cells migrate along nerves
and use blood vessels to disseminate (Nguyen et al., 2009), while
NCCs use the basement membrane of the ectoderm and dermomyotome and also migrate along nerves (Hall, 2008).
Besides the fact that cancer cells are similar to NCCs, there is
a group of cancers that are direct descendants of NCCs, some of
which are described below. One example is the group of tumors
from the sympathetic ganglia lineage known as neuroblastomas
and ganglioneuromas, which evidence a high expression of the
Hedgehog signaling pathway (Gershon et al., 2009) or TrkB/
BDNF signaling (Gryz and Meakin, 2003). Paragangliomas and
pheochromocytomas are highly vascularized tumors arising from
NC-derived tissues in the paraxial autonomic ganglia or in the
chromaffin cells of the adrenal medulla, respectively (Dahan et
al., 2005). One of the best known cancers derived from the NC
are malignant melanomas, which arise from the melanocytic lineage (Davies et al., 2002). Neurofibromatosis consists of tumors
that are derived from Schwann cells and are genetically inherited
(Evans et al., 2010).
The use of embryonic models and particularly NCCs to study
tumor cell phenotype determination affords an innovative approach
for investigating the boundaries of tumor cell plasticity and the
potential for reprogramming deadly cell types by targeting the
convergence of embryonic and tumorigenic signaling pathways.
A common problem in the testing of clinical drugs is that it is a
long and expensive process limited only to cultured cancer cells or
artificial tumor models. However, embryos from model organisms
12
G. A. Vega-Lopez et al.
can serve as a unique in vivo system for screening the effects of
specific factors or for high-throughput screening of small molecule
libraries (Maguire et al., 2015).
Cancer treatments at present include surgery, chemotherapy,
and radiation therapy, all of which are done at the cost of a lower
quality of life. It is of extreme importance to design therapies that
reduce collateral damage. Targeting signaling factors and processes have proven very effective; small molecule inhibitors of
Snail (Azmi et al., 2013) or c-Myc (Muller et al., 2014) are being
tested for their therapeutic potential. There is also a wide field
of research in the targeting of hedgehog signaling molecules for
cancer treatment (Abidi, 2014). Moreover, recent efforts are aimed
at identifying inhibitors of EMT in order to inhibit the invasive
capacity of cancer cells (Chua et al., 2012).
With a growing capacity to target particular signaling pathways
and molecules we will be able to tackle several pathologies imposed by this disease. Given the above results and evidence, it
is important to say that the understanding of NC development
can have potentially important implications for the treatment of
several types of cancers.
NCCs as stem cells: characteristics and potential applications
Due to the amazingly diversified array of cell types that they
generate, tNCCs represent an attractive model in the stem cell
field. The tNC population has multipotent and bipotent cells endowed with self-renewal, a bona fide property of stem cells. These
cells have the potency to yield glial cells, autonomic neurons and
myofibroblast/smooth muscle cells as well as melanocytes (Bittencourt et al., 2013). They are called NC stem cells (NCSCs)
(Achilleos and Trainor, 2012). These cells were first isolated from
mammalian multipotent NCCs taking advantage of the expression
of the p75 marker (Stemple and Anderson, 1992).
In rat and mouse, BMP and Wnt signaling are involved in the
maintenance of the undifferentiated state of NCCs (Kleber et
al., 2005). The transcription factor Sox10, which is expressed in
premigratory and migratory NCCs, functions in the maintenance
of multipotentiality of these cells both in vitro and in vivo (Kim et
al., 2003). Other regulators that control the pluripotent capacity
of NCCs are the chromatin remodelers CHD7 and SWI/SNF-B,
which act in conjunction with BMP and Wnt signaling (Fujita et
al., 2014). NCSCs are found not only in premigratory NCCs, but
also in NC derivatives such as the peripheral nerve, the DRG
and the gut, demonstrating that the migratory stream of some
NC populations are a mixture of specified and multipotent cells
(Morrison et al., 1999).
It has recently been shown in Xenopus laevis that, through the
process of gastrulation, NCCs retain pluripotency factors inherited
from stem cells of the blastula stage. These are the Snail1 and
Sox5 factors, which are responsible for keeping the developmental
capacities characteristic of NCCs (Buitrago-Delgado et al., 2015).
Major advances in this area have allowed scientists to unravel the
specific molecules responsible for favoring a specific NC lineage,
taking as a source NCSCs. Such is the case for TGFb, BMP4,
Neuregulin-1, Retinoic Acid, Edn3 and Delta-1, all of which favor
the development of specific NC sublineages in an instructive or
permissive manner (Le Douarin and Dupin, 2016).
A major breakthrough in NC biology has occurred recently, with
scientists being able to differentiate human pluripotent stem cells
(hPSC) into subtype specific NC cells, namely trunk NCCs (in
the presence of Retinoic Acid) and cranial NCCs (in the absence
of Retinoic Acid) (Huang et al., 2016). This discovery offers a
renewable human cell model to study NC biology and to develop
therapies against diseases arising from abnormal NC formation.
Therefore, the study of NC derived stem cells is of crucial importance because of their capacity to give rise to fully differentiated
and functional cell types, which contributes to the development
of regenerative medicine.
Concluding remarks
Fifteen years ago, many people argued that tNC played could
play a pivotal role in the development and differentiation of sensory
neurons and glia of the peripheral nervous system as well as in
the differentiation of adenomedullary cells and pigment cells of
the skin. Nowadays, advances in visualization and embryonic
manipulation technologies have allowed us to understand the
mechanisms that underlie the formation of the tNC in a much
deeper way, thus making possible a more specific assessment of
the key role of the tNC in the development of the peripheral and
enteric nervous system. However, the ability of tNC to generate
neural derivatives is not unique to this axial level, but instead is
shared by all crest cells. This ability, as well as with all other crest
potentials, is modulated by environmental cues.
Importantly, elucidating how and when different cues are
expressed and discovering the interacting proteins during the
formation, migration and differentiation of the trunk NC will contribute to our overall knowledge of the molecular basis of tNC
formation. Dissecting these and many other key issues will yield
important insights into the molecular control of NCCs development
and help to define the pathogenesis of various developmental
abnormalities (human disorders, diseases and syndromes) that
occur upon aberrant tNC development. Also, identification of the
signals required for trunk NCCs formation will facilitate ways to
generate hESCs, which will be beneficial for the application of
NCCs to regenerative medicine.
Thus, today our views of the significance of the tNC have
changed. Continued attention to these areas should unveil
numerous key players in the regulation of NCCs formation and
development over the next few years. Future research will focus
on understanding how these diverse signals work together to
pattern trunk NCCs. Further investigation into these questions
will clarify the mechanisms that dictate patterned tNC migration
and segmental peripheral nervous development.
Acknowledgments
We are grateful to our colleagues for helpful discussions. This publication
was supported by grants from ANPCyT-Foncyt to M.J.A. (PICT2013-1686
and PICT2015-1207), and by grants from CIUNT to M.J.A. (PIUNT 26/
D506). We specially thank to Ms. Virginia Mendez for proofreading and
Mr. Elias Maza and Mrs. Daniela Maza for their help with the graphics.
We regret that a lot of specific publications dealing with the subject of this
review could not be cited due to space limitations.
References
ABIDI, A. (2014). Hedgehog signaling pathway: a novel target for cancer therapy:
vismodegib, a promising therapeutic option in treatment of basal cell carcinomas.
Trunk neural crest cells
Indian J Pharmacol 46: 3-12.
ACHILLEOS, A. and TRAINOR, P.A. (2012). Neural crest stem cells: discovery,
properties and potential for therapy. Cell Res 22: 288-304.
AHLSTROM, J.D. and ERICKSON, C.A. (2009). The neural crest epithelial-mesenchymal transition in 4D: a ‘tail’ of multiple non-obligatory cellular mechanisms.
Development 136: 1801-1812.
AYBAR, M.J. and MAYOR, R. (2002). Early induction of neural crest cells: lessons
learned from frog, fish and chick. Curr Opin Genet Dev 12: 452-458.
AZMI, A.S., BOLLIG-FISCHER, A., BAO, B., PARK, B.J., LEE, S.H., YONG-SONG,
G., DYSON, G., REDDY, C.K., SARKAR, F.H. and MOHAMMAD, R.M. (2013).
Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype
induced by SNAIL-inhibitor GN-25. BMC systems biology 7: 85.
BAGGIOLINI, A., VARUM, S., MATEOS, J.M., BETTOSINI, D., JOHN, N., BONALLI, M.,
ZIEGLER, U., DIMOU, L., CLEVERS, H., FURRER, R. et al., (2015). Premigratory
and migratory neural crest cells are multipotent in vivo. Cell Stem Cell 16: 314-322.
BAKER, R.K. and ANTIN, P.B. (2003). Ephs and ephrins during early stages of chick
embryogenesis. Dev Dyn 228: 128-142.
BELMADANI, A., JUNG, H., REN, D. and MILLER, R.J. (2009). The chemokine
SDF-1/CXCL12 regulates the migration of melanocyte progenitors in mouse hair
follicles. Differentiation 77: 395-411.
BETANCUR, P., BRONNER-FRASER, M. and SAUKA-SPENGLER, T. (2010a).
Assembling neural crest regulatory circuits into a gene regulatory network. Annu
Rev Cell Dev Biol 26: 581-603.
BETANCUR, P., BRONNER-FRASER, M. and SAUKA-SPENGLER, T. (2010b).
Genomic code for Sox10 activation reveals a key regulatory enhancer for cranial
neural crest. Proc Natl Acad Sci USA 107: 3570-3575.
BITTENCOURT, D.A., DA COSTA, M.C., CALLONI, G.W., ALVAREZ-SILVA, M. and
TRENTIN, A.G. (2013). Fibroblast growth factor 2 promotes the self-renewal of bipotent glial smooth muscle neural crest progenitors. Stem Cells Dev 22: 1241-1251.
BONANO, M., TRIBULO, C., DE CALISTO, J., MARCHANT, L., SANCHEZ, S.S.,
MAYOR, R. and AYBAR, M.J. (2008). A new role for the Endothelin-1/Endothelin-A
receptor signaling during early neural crest specification. Dev Biol 323: 114-129.
BRITSCH, S., LI, L., KIRCHHOFF, S., THEURING, F., BRINKMANN, V., BIRCHMEIER,
C. and RIETHMACHER, D. (1998). The ErbB2 and ErbB3 receptors and their
ligand, neuregulin-1, are essential for development of the sympathetic nervous
system. Genes Dev 12: 1825-1836.
13
DUBAND, J.L., MONIER, F., DELANNET, M. and NEWGREEN, D. (1995). Epitheliummesenchyme transition during neural crest development. Acta Anat (Basel) 154:
63-78.
DUPIN, E. and LE DOUARIN, N.M. (2003). Development of melanocyte precursors
from the vertebrate neural crest. Oncogene 22: 3016-3023.
DUPIN, E. and SOMMER, L. (2012). Neural crest progenitors and stem cells: from
early development to adulthood. Dev Biol 366: 83-95.
DYACHUK, V., FURLAN, A., SHAHIDI, M.K., GIOVENCO, M., KAUKUA, N., KONSTANTINIDOU, C., PACHNIS, V., MEMIC, F., MARKLUND, U., MULLER, T. et
al., (2014). Neurodevelopment. Parasympathetic neurons originate from nerveassociated peripheral glial progenitors. Science 345: 82-87.
ERICKSON, C.A., DUONG, T.D. and TOSNEY, K.W. (1992). Descriptive and experimental analysis of the dispersion of neural crest cells along the dorsolateral
path and their entry into ectoderm in the chick embryo. Dev Biol 151: 251-272.
ERWIN, D.H. and DAVIDSON, E.H. (2009). The evolution of hierarchical gene regulatory networks. Nature Review Genet.10: 141-148.
ETCHEVERS, H.C., AMIEL, J. and LYONNET, S. (2006). Molecular bases of human
neurocristopathies. Adv. Exp. Med. Biol. 589: 213-234.
ETCHEVERS, H.C., VINCENT, C., LE DOUARIN, N.M. and COULY, G.F. (2001).
The cephalic neural crest provides pericytes and smooth muscle cells to all blood
vessels of the face and forebrain. Development 128: 1059-1068.
EVANS, D.G., HOWARD, E., GIBLIN, C., CLANCY, T., SPENCER, H., HUSON,
S.M. and LALLOO, F. (2010). Birth incidence and prevalence of tumor-prone
syndromes: estimates from a UK family genetic register service. Am. J. Med.
Genet. Part A 152A: 327-332.
FANTAUZZO, K.A. and SORIANO, P. (2015). Receptor tyrosine kinase signaling:
regulating neural crest development one phosphate at a time. Curr Top Dev Biol
111: 135-182.
FERNANDEZ, J.P., AGUERO, T.H., VEGA LOPEZ, G.A., MARRANZINO, G., CERRIZUELA, S. and AYBAR, M.J. (2014). Developmental expression and role of
Kinesin Eg5 during Xenopus laevis embryogenesis. Dev Dyn 243: 527-540.
FUJITA, K., OGAWA, R., KAWAWAKI, S. and ITO, K. (2014). Roles of chromatin remodelers in maintenance mechanisms of multipotency of mouse trunk neural crest
cells in the formation of neural crest-derived stem cells. Mech Dev 133: 126-145.
GAMMILL, L.S. and ROFFERS-AGARWAL, J. (2010). Division of labor during trunk
neural crest development. Dev Biol 344: 555-65.
BRODERS-BONDON, F., PAUL-GILLOTEAUX, P., GAZQUEZ, E., HEYSCH, J.,
PIEL, M., MAYOR, R., LAMBRIS, J.D. and DUFOUR, S. (2016). Control of the
collective migration of enteric neural crest cells by the Complement anaphylatoxin
C3a and N-cadherin. Dev Biol 414: 85-99.
GERSHON, T.R., SHIRAZ, A., QIN, L.X., GERALD, W.L., KENNEY, A.M. and
CHEUNG, N.K. (2009). Enteric neural crest differentiation in ganglioneuromas
implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis.
PLoS One 4: e7491.
BRONNER, M. (2015). Confetti clarifies controversy: neural crest stem cells are
multipotent. Cell Stem Cell 16: 217-218.
GONG, S.G. (2014). Cranial neural crest: migratory cell behavior and regulatory
networks. Exp Cell Res 325: 90-95.
BUITRAGO-DELGADO, E., NORDIN, K., RAO, A., GEARY, L. and LABONNE, C.
(2015). NEURODEVELOPMENT. Shared regulatory programs suggest retention
of blastula-stage potential in neural crest cells. Science 348: 1332-1335.
GORDON, C.T., WADE, C., BRINAS, I. and FARLIE, P.G. (2011). CXCL14 expression
during chick embryonic development. Int J Dev Biol 55: 335-340.
CASINI, P., ORI, M., AVENOSO, A., D’ASCOLA, A., TRAINA, P., MATTINA, W.,
PERRIS, R., CAMPO, G.M., CALATRONI, A., NARDI, I. et al., (2008). Identification and gene expression of versican during early development of Xenopus. Int
J Dev Biol 52: 993-998.
COLLAZO, A., BRONNER-FRASER, M. and FRASER, S.E. (1993). Vital dye labelling
of Xenopus laevis trunk neural crest reveals multipotency and novel pathways of
migration. Development 118: 363-376.
CHEUNG, M., CHABOISSIER, M.C., MYNETT, A., HIRST, E., SCHEDL, A. and
BRISCOE, J. (2005). The transcriptional control of trunk neural crest induction,
survival, and delamination. Dev Cell 8: 179-192.
CHUA, K.N., SIM, W.J., RACINE, V., LEE, S.Y., GOH, B.C. and THIERY, J.P. (2012). A
cell-based small molecule screening method for identifying inhibitors of epithelialmesenchymal transition in carcinoma. PLoS One 7: e33183.
DAHAN, L., ATLAN, D., BOUCHE, O., MITRY, E., RIES, P., ARTRU, P., RICHARD,
K., LLEDO, G., NGUYEN, T., ROUGIER, P. et al., (2005). Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2
reduce the toxic effects of the MacDonald regimen? A report on 23 patients.
Gastroenterol. Clin. Biol. 29: 11-15.
DAVIES, T.W., TREASURE, F.P., WELCH, A.A. and DAY, N.E. (2002). Diet and basal cell
skin cancer: results from the EPIC-Norfolk cohort. Br. J. Dermatol. 146: 1017-1022.
GREENHILL, E.R., ROCCO, A., VIBERT, L., NIKAIDO, M. and KELSH, R.N. (2011).
An iterative genetic and dynamical modelling approach identifies novel features
of the gene regulatory network underlying melanocyte development. PLoS Genet
7: e1002265.
GROVES, A.K., GEORGE, K.M., TISSIER-SETA, J.-P., ENGEL, J.D., BRUNET,
J.-F. and ANDERSON, D.J. (1995). Differential regulation of transcription factor
gene expression and phenotypic markers in developing sympathetic neurons.
Development 121: 887-901.
GRYZ, E.A. and MEAKIN, S.O. (2003). Acidic substitution of the activation loop
tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth
factor-independent, differentiation and cell cycle arrest in the human neuroblastoma
cell line, SY5Y. Oncogene 22: 8774-85.
HALL, B.K. (2008). The neural crest and neural crest cells: discovery and significance
for theories of embryonic organization. J. Biosci. 33: 781-93.
HARRIS, M.L., HALL, R. and ERICKSON, C.A. (2008). Directing pathfinding along
the dorsolateral path - the role of EDNRB2 and EphB2 in overcoming inhibition.
Development 135: 4113-22.
HINDLEY, C.J., CONDURAT, A.L., MENON, V., THOMAS, R., AZMITIA, L.M., DAVIS,
J.A. and PRUSZAK, J. (2016). The Hippo pathway member YAP enhances human
neural crest cell fate and migration. Sci Rep 6: 23208.
HONJO, Y. and EISEN, J.S. (2005). Slow muscle regulates the pattern of trunk neural
14
G. A. Vega-Lopez et al.
crest migration in zebrafish. Development 132: 4461-70.
HONMA, Y., ARAKI, T., GIANINO, S., BRUCE, A., HEUCKEROTH, R., JOHNSON,
E. and MILBRANDT, J. (2002). Artemin is a vascular-derived neurotropic factor
for developing sympathetic neurons. Neuron 35: 267-282.
HUANG, M., MILLER, M.L., MCHENRY, L.K., ZHENG, T., ZHEN, Q., ILKHANIZADEH,
S., CONKLIN, B.R., BRONNER, M.E. and WEISS, W.A. (2016). Generating trunk
neural crest from human pluripotent stem cells. Sci Rep 6: 19727.
ITO, K. and MORITA, T. (1995). Role of retinoic acid in mouse neural crest cell
development in vitro. Dev Dyn 204: 211-8.
JIA, L., CHENG, L. and RAPER, J. (2005). Slit/Robo signaling is necessary to confine
early neural crest cells to the ventral migratory pathway in the trunk. Dev Biol
282: 411-21.
KARUNASENA, E., MCIVER, L.J., BAVARVA, J.H., WU, X., ZHU, H. and GARNER, H.R.
(2015). “Cut from the same cloth”: Shared microsatellite variants among cancers
link to ectodermal tissues-neural tube and crest cells. Oncotarget 8:22038-22047.
KAWASAKI-NISHIHARA, A., NISHIHARA, D., NAKAMURA, H. and YAMAMOTO,
H. (2011). ET3/Ednrb2 signaling is critically involved in regulating melanophore
migration in Xenopus. Dev Dyn 240: 1454-1466.
KAWASAKI, T., BEKKU, Y., SUTO, F., KITSUKAWA, T., TANIGUCHI, M., NAGATSU,
I., NAGATSU, T., ITOH, K., YAGI, T. and FUJISAWA, H. (2002). Requirement of
neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous
system. Development 129: 671-680.
KELSH, R.N. (2006). Sorting out Sox10 functions in neural crest development.
Bioessays 28: 788-798.
KELSH, R.N., HARRIS, M.L., COLANESI, S. and ERICKSON, C.A. (2009). Stripes
and belly-spots -- a review of pigment cell morphogenesis in vertebrates. Semin
Cell Dev Biol 20: 90-104.
KEROSUO, L. and BRONNER-FRASER, M. (2012). What is bad in cancer is good
in the embryo: importance of EMT in neural crest development. Semin Cell Dev
Biol 23: 320-332.
KIM, J., LO, L., DORMAND, E. and ANDERSON, D.J. (2003). SOX10 maintains
multipotency and inhibits neuronal differentiation of neural crest stem cells.
Neuron 38: 17-31.
KLEBER, M., LEE, H.Y., WURDAK, H., BUCHSTALLER, J., RICCOMAGNO, M.M.,
ITTNER, L.M., SUTER, U., EPSTEIN, D.J. and SOMMER, L. (2005). Neural
crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell
Biol 169: 309-320.
KRISPIN, S., NITZAN, E., KASSEM, Y. and KALCHEIM, C. (2010). Evidence for a
dynamic spatiotemporal fate map and early fate restrictions of premigratory avian
neural crest. Development 137: 585-95.
KULESA, P.M., BAILEY, C.M., KASEMEIER-KULESA, J.C. and MCLENNAN, R. (2010).
Cranial neural crest migration: new rules for an old road. Dev Biol 344: 543-554.
KUO, B.R. and ERICKSON, C.A. (2010). Regional differences in neural crest morphogenesis. Cell Adh Migr 4: 567-585.
KUO, B.R. and ERICKSON, C.A. (2011). Vagal neural crest cell migratory behavior:
A transition between the cranial and trunk crest. Dev Dyn 240: 2084-2100.
KURIYAMA, S. and MAYOR, R. (2008). Molecular analysis of neural crest migration.
Philos Trans R Soc Lond B Biol Sci 363: 1349-1362.
LE DOUARIN, N. and KALCHEIM, C. (1999). The neural crest. Cambridge University
Press.
LE DOUARIN, N.M. and DUPIN, E. (2016). Chapter Thirty-Eight-The Pluripotency
of Neural Crest Cells and Their Role in Brain Development. Curr Top Dev Biol
116: 659-678.
LEE, H.O., LEVORSE, J.M. and SHIN, M.K. (2003). The endothelin receptor-B is
required for the migration of neural crest-derived melanocyte and enteric neuron
precursors. Dev Biol 259: 162-175.
LEE, H.Y., KLEBER, M., HARI, L., BRAULT, V., SUTER, U., TAKETO, M.M., KEMLER,
R. and SOMMER, L. (2004). Instructive role of Wnt/beta-catenin in sensory fate
specification in neural crest stem cells. Science 303: 1020-1023.
LIU, J.A., WU, M.H., YAN, C.H., CHAU, B.K., SO, H., NG, A., CHAN, A., CHEAH,
K.S., BRISCOE, J. and CHEUNG, M. (2013). Phosphorylation of Sox9 is required
for neural crest delamination and is regulated downstream of BMP and canonical
Wnt signaling. Proc Natl Acad Sci USA 110: 2882-2887.
LUMSDEN, A. and GUTHRIE, S. (1991). Alternating patterns of cell surface properties and neural crest cell migration during segmentation of the chick hindbrain.
Dev Suppl Suppl 2: 9-15.
MAGUIRE, L.H., THOMAS, A.R. and GOLDSTEIN, A.M. (2015). Tumors of the neural
crest: Common themes in development and cancer. Dev Dyn 244: 311-322.
MCGRAW, H.F., SNELSON, C.D., PRENDERGAST, A., SULI, A. and RAIBLE, D.W.
(2012). Postembryonic neuronal addition in Zebrafish dorsal root ganglia is
regulated by Notch signaling. Neural Dev 7: 1-13.
MCKINNEY, M.C., FUKATSU, K., MORRISON, J., MCLENNAN, R., BRONNER,
M.E. and KULESA, P.M. (2013). Evidence for dynamic rearrangements but lack
of fate or position restrictions in premigratory avian trunk neural crest. Development 140: 820-830.
MCLENNAN, R., DYSON, L., PRATHER, K.W., MORRISON, J.A., BAKER, R.E.,
MAINI, P.K. and KULESA, P.M. (2012). Multiscale mechanisms of cell migration
during development: theory and experiment. Development 139: 2935-2944.
MCLENNAN, R., SCHUMACHER, L.J., MORRISON, J.A., TEDDY, J.M., RIDENOUR,
D.A., BOX, A.C., SEMERAD, C.L., LI, H., MCDOWELL, W., KAY, D. et al., (2015).
Neural crest migration is driven by a few trailblazer cells with a unique molecular
signature narrowly confined to the invasive front. Development 142: 2014-2025.
MINOUX, M. and RIJLI, F.M. (2010). Molecular mechanisms of cranial neural crest cell
migration and patterning in craniofacial development. Development 137: 2605-2621.
MORI-AKIYAMA, Y., AKIYAMA, H., ROWITCH, D.H. and DE CROMBRUGGHE, B.
(2003). Sox9 is required for determination of the chondrogenic cell lineage in the
cranial neural crest. Proc Natl Acad Sci USA 100: 9360-9365.
MORIKAWA, Y., DAI, Y.S., HAO, J., BONIN, C., HWANG, S. and CSERJESI, P.
(2005). The basic helix‐loop‐helix factor Hand2 regulates autonomic nervous
system development. Dev. Dynam. 234: 613-621.
MORRISON, S.J., WHITE, P.M., ZOCK, C. and ANDERSON, D.J. (1999). Prospective
identification, isolation by flow cytometry, and in vivo self-renewal of multipotent
mammalian neural crest stem cells. Cell 96: 737-749.
MUKENDI, C., DEAN, N., LALA, R., SMITH, J., BRONNER, M.E. and NIKITINA,
N.V. (2016). Evolution of the vertebrate claudin gene family: insights from a basal
vertebrate, the sea lamprey. Int J Dev Biol 60: 39-51.
MULLER, I., LARSSON, K., FRENZEL, A., OLIYNYK, G., ZIRATH, H., PROCHOWNIK,
E.V., WESTWOOD, N.J. and HENRIKSSON, M.A. (2014). Targeting of the MYCN
protein with small molecule c-MYC inhibitors. PLoS One 9: e97285.
NAKAGAWA, S. and TAKEICHI, M. (1995). Neural crest cell-cell adhesion controlled
by sequential and subpopulation-specific expression of novel cadherins. Development 121: 1321-1332.
NATARAJAN, D., MARCOS-GUTIERREZ, C., PACHNIS, V. and DE GRAAFF,
E. (2002). Requirement of signalling by receptor tyrosine kinase RET for the
directed migration of enteric nervous system progenitor cells during mammalian
embryogenesis. Development 129: 5151-5160.
NGUYEN, D.X., BOS, P.D. and MASSAGUE, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284.
NIEHRS, C. (2004). Regionally specific induction by the Spemann-Mangold organizer.
Nat Rev Genet 5: 425-434.
NIETO, M.A. (2009). Epithelial-Mesenchymal Transitions in development and disease:
old views and new perspectives. Int J Dev Biol 53: 1541-1547.
NITZAN, E., KRISPIN, S., PFALTZGRAFF, E.R., KLAR, A., LABOSKY, P.A. and
KALCHEIM, C. (2013). A dynamic code of dorsal neural tube genes regulates the
segregation between neurogenic and melanogenic neural crest cells. Development 140: 2269-2279.
OSORIO, L., TEILLET, M.A., PALMEIRIM, I. and CATALA, M. (2009). Neural crest
ontogeny during secondary neurulation: a gene expression pattern study in the
chick embryo. Int J Dev Biol 53: 641-648.
PANZA, E., KNOWLES, C.H., GRAZIANO, C., THAPAR, N., BURNS, A.J., SERI,
M., STANGHELLINI, V. and DE GIORGIO, R. (2012). Genetics of human enteric
neuropathies. Prog. Neurobiol. 96: 176-189.
PARICHY, D.M., RAWLS, J.F., PRATT, S.J., WHITFIELD, T.T. and JOHNSON, S.L.
(1999). Zebrafish sparse corresponds to an orthologue of c-kit and is required
for the morphogenesis of a subpopulation of melanocytes, but is not essential for
hematopoiesis or primordial germ cell development. Development 126: 3425-3436.
PATTYN, A., MORIN, X., CREMER, H., GORIDIS, C. and BRUNET, J.F. (1999). The
homeobox gene Phox2b is essential for the development of autonomic neural
crest derivatives. Nature 399: 366-370.
PETER, I. and DAVIDSON, E.H. (2015). Genomic control process: development and
Trunk neural crest cells
evolution. Academic Press.
PINGAULT, V., BONDURAND, N., KUHLBRODT, K., GOERICH, D.E., PRÉHU, M.-O.,
PULITI, A., HERBARTH, B., HERMANS-BORGMEYER, I., LEGIUS, E. and MATTHIJS, G. (1998). SOX10 mutations in patients with Waardenburg-Hirschsprung
disease. Nat Genet 18: 171-173.
POWELL, D.R., WILLIAMS, J.S., HERNANDEZ-LAGUNAS, L., SALCEDO, E.,
O’BRIEN, J.H. and ARTINGER, K.B. (2015). Cdon promotes neural crest migration by regulating N-cadherin localization. Dev Biol 407: 289-299.
RAIBLE, D.W., WOOD, A., HODSDON, W., HENION, P.D., WESTON, J.A. and
EISEN, J.S. (1992). Segregation and early dispersal of neural crest cells in the
embryonic zebrafish. Dev Dyn 195: 29-42.
RANSCHT, B. and BRONNER-FRASER, M. (1991). T-cadherin expression alternates
with migrating neural crest cells in the trunk of the avian embryo. Development
111: 15-22.
RICHARDSON, J., GAUERT, A., BRIONES MONTECINOS, L., FANLO, L., ALHASHEM, Z.M., ASSAR, R., MARTI, E., KABLA, A., HARTEL, S. and LINKER,
C. (2016). Leader Cells Define Directionality of Trunk, but Not Cranial, Neural
Crest Cell Migration. Cell Rep 15: 2076-2088.
RIOS, A.C., SERRALBO, O., SALGADO, D. and MARCELLE, C. (2011). Neural
crest regulates myogenesis through the transient activation of NOTCH. Nature
473: 532-535.
ROGERS, C.D., SAXENA, A. and BRONNER, M.E. (2013). Sip1 mediates an Ecadherin-to-N-cadherin switch during cranial neural crest EMT. J Cell Biol 203:
835-847.
SAITO, D., TAKASE, Y., MURAI, H. and TAKAHASHI, Y. (2012). The dorsal aorta
initiates a molecular cascade that instructs sympatho-adrenal specification. Science 336: 1578-1581.
15
SOMMER, L., SHAH, N., RAO, M. and ANDERSON, D.J. (1995). The cellular function
of MASH1 in autonomic neurogenesis. Neuron 15: 1245-1258.
SQUARE, T., JANDZIK, D., CATTELL, M., HANSEN, A. and MEDEIROS, D.M. (2016).
Embryonic expression of endothelins and their receptors in lamprey and frog
reveals stem vertebrate origins of complex Endothelin signaling. Sci Rep 6: 34282.
STEMPLE, D.L. and ANDERSON, D.J. (1992). Isolation of a stem cell for neurons
and glia from the mammalian neural crest. Cell 71: 973-985.
SZABO, A. and MAYOR, R. (2016). Modelling collective cell migration of neural crest.
Curr. Opin. Cell Biol. 42: 22-28.
TANEYHILL, L.A. (2008). To adhere or not to adhere: the role of Cadherins in neural
crest development. Cell Adh Migr 2: 223-230.
TAYLOR, K.M. and LABONNE, C. (2007). Modulating the activity of neural crest
regulatory factors. Curr Opin Genet Dev 17: 326-31.
THEVENEAU, E., DUBAND, J.L. and ALTABEF, M. (2007). Ets-1 confers cranial
features on neural crest delamination. PLoS One 2: e1142.
THEVENEAU, E., MARCHANT, L., KURIYAMA, S., GULL, M., MOEPPS, B., PARSONS,
M. and MAYOR, R. (2010). Collective chemotaxis requires contact-dependent
cell polarity. Dev Cell 19: 39-53.
THIERY, J.P. and SLEEMAN, J.P. (2006). Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
TOSNEY, K.W. (2004). Long-distance cue from emerging dermis stimulates neural
crest melanoblast migration. Dev Dyn 229: 99-108.
URIBE, R.A. and BRONNER, M.E. (2015). Meis3 is required for neural crest invasion of the gut during zebrafish enteric nervous system development. Mol Biol
Cell 26: 3728-3740.
SANTIAGO, A. and ERICKSON, C.A. (2002). Ephrin-B ligands play a dual role in the
control of neural crest cell migration. Development 129: 3621-3632.
VALLIN, J., GIRAULT, J.M., THIERY, J.P. and BRODERS, F. (1998). Xenopus
cadherin-11 is expressed in different populations of migrating neural crest cells.
Mech Dev 75: 171-174.
SCHWARZ, Q., MADEN, C.H., VIEIRA, J.M. and RUHRBERG, C. (2009). Neuropilin 1 signaling guides neural crest cells to coordinate pathway choice with cell
specification. Proc Natl Acad Sci USA 106: 6164-6169.
WEHRLE-HALLER, B., MELLER, M. and WESTON, J.A. (2001). Analysis of melanocyte precursors in Nf1 mutants reveals that MGF/KIT signaling promotes directed
cell migration independent of its function in cell survival. Dev Biol 232: 471-483.
SERBEDZIJA, G.N., FRASER, S.E. and BRONNER-FRASER, M. (1990). Pathways
of trunk neural crest cell migration in the mouse embryo as revealed by vital dye
labelling. Development 108: 605-612.
WYNN, M.L., RUPP, P., TRAINOR, P.A., SCHNELL, S. and KULESA, P.M. (2013).
Follow-the-leader cell migration requires biased cell-cell contact and local microenvironmental signals. Phys Biol 10: 035003.
SHOVAL, I., LUDWIG, A. and KALCHEIM, C. (2007). Antagonistic roles of full-length
N-cadherin and its soluble BMP cleavage product in neural crest delamination.
Development 134: 491-501.
YASUMI, T., INOUE, M., MARUHASHI, M., KAMACHI, Y., HIGASHI, Y., KONDOH,
H. and UCHIKAWA, M. (2016). Regulation of trunk neural crest delamination
by deltaEF1 and Sip1 in the chicken embryo. Dev Growth Differ 58: 205-214.
SIMKIN, J.E., ZHANG, D., ROLLO, B.N. and NEWGREEN, D.F. (2013). Retinoic
Acid Upregulates Ret and Induces Chain Migration and Population Expansion in
Vagal Neural Crest Cells to Colonise the Embryonic Gut. PLoS One 8: e64077.
ZHANG, S., SU, Y., GAO, J., ZHANG, C. and TANAKA, H. (2016). A potential inhibitory function of draxin in regulating mouse trunk neural crest migration. In vitro
Cell. Dev. Biol. -Animal 1-11.
SIMOES-COSTA, M.S., MCKEOWN, S.J., TAN-CABUGAO, J., SAUKA-SPENGLER, T.
and BRONNER, M.E. (2012). Dynamic and differential regulation of stem cell factor
FoxD3 in the neural crest is Encrypted in the genome. PLoS Genet 8: e1003142.
ZUHDI, N., ORTEGA, B., GIOVANNONE, D., RA, H., REYES, M., ASENCION, V.,
MCNICOLL, I., MA, L. and DE BELLARD, M.E. (2015). Slit molecules prevent
entrance of trunk neural crest cells in developing gut. Int J Dev Neurosci 41: 8-16.
Further Related Reading, published previously in the Int. J. Dev. Biol.
Evolution of the vertebrate claudin gene family: insights from a basal vertebrate, the sea lamprey
Christian Mukendi, Nicholas Dean, Rushil Lala, Jeramiah Smith, Marianne E. Bronner and Natalya V. Nikitina
Int. J. Dev. Biol. 60: 39 - 51 (2016)
http://dx.doi.org/10.1387/ijdb.150364nn
Bone morphogenetic protein 4 promotes craniofacial neural crest induction from human pluripotent stem cells
Sumiyo Mimura, Mika Suga, Kaori Okada, Masaki Kinehara, Hiroki Nikawa and Miho K. Furue
Int. J. Dev. Biol. 60: 21 - 28 (2016)
http://dx.doi.org/10.1387/ijdb.160040mk
Two different vestigial like 4 genes are differentially expressed during Xenopus laevis development
María-Guadalupe Barrionuevo, Manuel J. Aybar and Celeste Tríbulo
Int. J. Dev. Biol. (2014) 58: 369-377
http://dx.doi.org/10.1387/ijdb.130353ct
The transcriptional coactivators Yap and TAZ are expressed during early Xenopus
development
Susumu Nejigane, Yoshikazu Haramoto, Makoto Okuno, Shuji Takahashi and Makoto
Asashima.
Int. J. Dev. Biol. 55: 121 - 126 (2011)
http://dx.doi.org/10.1387/ijdb.103130sn
5 yr ISI Impact Factor (2013) = 2.879